P4489Rivaroxaban, a direct factor Xa inhibitor, ameliorates angiotensin II-induced renal damage through inhibition of protease-activated receptor pathway-mediated inflammatory response

Autor:	Ken Okumura, Michiko Shimada, Makoto Tanaka, Noritomo Narita, Hiroaki Ichikawa, Yoshihiro Kimura, K. Nishizaki, Masato Narita, Manabu Yonekura, M. Seno, Hirofumi Tomita, Tomohiro Osanai
Rok vydání:	2017
Předmět:	medicine.drug_mechanism_of_action Renal damage business.industry Inflammatory response Factor Xa Inhibitor medicine Protease-activated receptor Pharmacology Cardiology and Cardiovascular Medicine business Angiotensin II
Zdroj:	European Heart Journal. 38
ISSN:	1522-9645 0195-668X
DOI:	10.1093/eurheartj/ehx504.p4489
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::439e572536884398401fef49b00b29fa https://doi.org/10.1093/eurheartj/ehx504.p4489 Zobrazit plný text záznamu